230 related articles for article (PubMed ID: 10230181)
1. Stimulant medications.
Greenhill LL; Halperin JM; Abikoff H
J Am Acad Child Adolesc Psychiatry; 1999 May; 38(5):503-12. PubMed ID: 10230181
[TBL] [Abstract][Full Text] [Related]
2. Diagnosis and treatment of attention deficit hyperactivity disorder (ADHD).
NIH Consens Statement; 1998 Nov 16-18; 16(2):1-37. PubMed ID: 10868163
[TBL] [Abstract][Full Text] [Related]
3. An update on central nervous system stimulant formulations in children and adolescents with attention-deficit/hyperactivity disorder.
Chavez B; Sopko MA; Ehret MJ; Paulino RE; Goldberg KR; Angstadt K; Bogart GT
Ann Pharmacother; 2009 Jun; 43(6):1084-95. PubMed ID: 19470858
[TBL] [Abstract][Full Text] [Related]
4. Evolution of the treatment of attention-deficit/hyperactivity disorder in children: a review.
Findling RL
Clin Ther; 2008 May; 30(5):942-57. PubMed ID: 18555941
[TBL] [Abstract][Full Text] [Related]
5. Impact of comorbid autism spectrum disorders on stimulant response in children with attention deficit hyperactivity disorder: a retrospective and prospective effectiveness study.
Santosh PJ; Baird G; Pityaratstian N; Tavare E; Gringras P
Child Care Health Dev; 2006 Sep; 32(5):575-83. PubMed ID: 16919137
[TBL] [Abstract][Full Text] [Related]
6. Dexmethylphenidate for attention deficit hyperactivity disorder.
Coury D
Expert Opin Pharmacother; 2009 Nov; 10(16):2679-85. PubMed ID: 19874250
[TBL] [Abstract][Full Text] [Related]
7. Treatment of attention-deficit/hyperactivity disorder: overview of the evidence.
Brown RT; Amler RW; Freeman WS; Perrin JM; Stein MT; Feldman HM; Pierce K; Wolraich ML; ;
Pediatrics; 2005 Jun; 115(6):e749-57. PubMed ID: 15930203
[TBL] [Abstract][Full Text] [Related]
8. Efficacy and safety of mixed amphetamine salts extended release (Adderall XR) in the management of attention-deficit/hyperactivity disorder in adolescent patients: a 4-week, randomized, double-blind, placebo-controlled, parallel-group study.
Spencer TJ; Wilens TE; Biederman J; Weisler RH; Read SC; Pratt R
Clin Ther; 2006 Feb; 28(2):266-79. PubMed ID: 16678648
[TBL] [Abstract][Full Text] [Related]
9. Sleep in children with attention-deficit hyperactivity disorder (ADHD): a review of naturalistic and stimulant intervention studies.
Cohen-Zion M; Ancoli-Israel S
Sleep Med Rev; 2004 Oct; 8(5):379-402. PubMed ID: 15336238
[TBL] [Abstract][Full Text] [Related]
10. Growth deficits in children with attention deficit hyperactivity disorder.
Spencer T; Biederman J; Wilens T
Pediatrics; 1998 Aug; 102(2 Pt 3):501-6. PubMed ID: 9685453
[TBL] [Abstract][Full Text] [Related]
11. Innovations in attention-deficit/hyperactivity disorder pharmacotherapy: long-acting stimulant and nonstimulant treatments.
Stein MA
Am J Manag Care; 2004 Jul; 10(4 Suppl):S89-98. PubMed ID: 15352535
[TBL] [Abstract][Full Text] [Related]
12. Safety of stimulant treatment in attention deficit hyperactivity disorder: Part I.
Merkel RL; Kuchibhatla A
Expert Opin Drug Saf; 2009 Nov; 8(6):655-68. PubMed ID: 19785509
[TBL] [Abstract][Full Text] [Related]
13. Effect of stimulants on height and weight: a review of the literature.
Faraone SV; Biederman J; Morley CP; Spencer TJ
J Am Acad Child Adolesc Psychiatry; 2008 Sep; 47(9):994-1009. PubMed ID: 18580502
[TBL] [Abstract][Full Text] [Related]
14. Long-term outcomes of stimulant medication in attention-deficit hyperactivity disorder.
Poulton A
Expert Rev Neurother; 2006 Apr; 6(4):551-61. PubMed ID: 16623654
[TBL] [Abstract][Full Text] [Related]
15. Cardiac safety of central nervous system stimulants in children and adolescents with attention-deficit/hyperactivity disorder.
Winterstein AG; Gerhard T; Shuster J; Johnson M; Zito JM; Saidi A
Pediatrics; 2007 Dec; 120(6):e1494-501. PubMed ID: 18055666
[TBL] [Abstract][Full Text] [Related]
16. Efficacy and safety of modafinil film-coated tablets in children and adolescents with attention-deficit/hyperactivity disorder: results of a randomized, double-blind, placebo-controlled, flexible-dose study.
Biederman J; Swanson JM; Wigal SB; Kratochvil CJ; Boellner SW; Earl CQ; Jiang J; Greenhill L
Pediatrics; 2005 Dec; 116(6):e777-84. PubMed ID: 16322134
[TBL] [Abstract][Full Text] [Related]
17. Psychopharmacological interventions.
Biederman J; Spencer TJ
Child Adolesc Psychiatr Clin N Am; 2008 Apr; 17(2):439-58, xi. PubMed ID: 18295155
[TBL] [Abstract][Full Text] [Related]
18. A comparative analysis of antidepressants and stimulants for the treatment of adults with attention-deficit hyperactivity disorder.
Higgins ES
J Fam Pract; 1999 Jan; 48(1):15-20. PubMed ID: 9934377
[TBL] [Abstract][Full Text] [Related]
19. An n-of-1 trial service in clinical practice: testing the effectiveness of stimulants for attention-deficit/hyperactivity disorder.
Nikles CJ; Mitchell GK; Del Mar CB; Clavarino A; McNairn N
Pediatrics; 2006 Jun; 117(6):2040-6. PubMed ID: 16740846
[TBL] [Abstract][Full Text] [Related]
20. Effects of long-term psychostimulant medication on growth of children with ADHD.
Zachor DA; Roberts AW; Hodgens JB; Isaacs JS; Merrick J
Res Dev Disabil; 2006; 27(2):162-74. PubMed ID: 15955659
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
